Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Cara Therapeutics (CARA)

14.22 +0.16 (+1.14%)

8/16/2017  1:03pm

Open:

14.02

Pre. Close:

14.06

High:

14.50

Low:

14.01

Volume:

298,465

Market Cap:

463.30M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

14.58 - 14.67

14.67 - 14.94

Low:

13.05 - 13.22

13.22 - 13.78

Close:

13.34 - 13.58

13.58 - 14.35

Technical analysis  (as of: 2017-08-16 1:07:53 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 17.57     One year: 19.27

Support:

Support1: 12.68    Support2: 10.55

Resistance:

Resistance1: 15.04    Resistance2: 16.50

Pivot:

14.14

Moving Averages:

MA(5): 14.08     MA(20): 14.38

MA(100): 16.67     MA(250): 12.99

MACD:

MACD(12,26): -0.51     Signal(12,26,9): -0.63

%K %D:

%K(14,3): 38.16     %D(3): 35.81

RSI:

RSI(14): 46.32

52-Week:

High: 28.50  Low: 5.27  Change(%): 132.5

Average Vol(K):

3-Month: 267646  10-Days 109279

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CARA has closed below upper band by 46.2%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CARA's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 04 Aug 2017 12:22:30 GMT
Cara Therapeutics: Opportunity On The Dip

Sun, 30 Jul 2017 12:11:15 GMT
The case for GW Pharmaceuticals plc

Fri, 04 Aug 2017 19:41:15 GMT
Why Cara Therapeutics Shares Are Surging 23% Today

Mon, 07 Aug 2017 22:30:00 GMT
A Possible Bump In The Road Ahead For CARA Therapeutics' Lead Drug Candidate ...

Tue, 01 Aug 2017 11:03:45 GMT
Cara Therapeutics Appoints Mani Mohindru, Ph.D., Chief Financial Officer

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

32.58

Shares Float (M)

27.43

% Held by Insiders

29.45

% Held by Institutions

45.70

Shares Short (K)

523

Shares Short Prior Month (K)

567

Stock Financials

EPS

-2.520

EPS Est. Current Year

-1.780

EPS Est. Next Year

-1.860

EPS Est. Next Quarter

-0.380

Forward EPS

-2.271

Book Value (p.s.)

0.900

PEG Ratio

Profit Margin

Operating Margin

-7249.95

Return on Assets (ttm)

-39.3

Return on Equity (ttm)

-67.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.003

Sales Per Share

EBITDA (p.s.)

-1.986

Qtrly Earnings Growth

Operating Cash Flow (M)

-59.65

Levered Free Cash Flow (M)

-36.44

FoxReading.com

Valuation

P/E

-5.65

P/E Growth Ratio

0.01

P/BV

15.83

P/S

15475500032.00

P/CF

-7.78

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.